Observations placeholder
Tikosyn and Dofetilide
Identifier
015753
Type of Spiritual Experience
Number of hallucinations: 8
Background
A description of the experience
Dofetilide is a class III antiarrhythmic agent. It is marketed under the trade name Tikosyn, and is available in the United States in capsules containing 125, 250, and 500 µg of dofetilide. It is not available in Europe or Australia
Due to the pro-arrhythmic potential of dofetilide, it is only available by prescription from physicians who have undergone specific training in the risks of treatment with dofetilide. In addition, it is only available by mail order or through specially trained local pharmacies.
Dofetilide is used for the maintenance of sinus rhythm in individuals prone to the occurrence of atrial fibrillation and flutter arrhythmias, and for chemical cardioversion to sinus rhythm from atrial fibrillation and flutter.
On Dec, 26, 2016 8,033 people reported to have side effects when taking Tikosyn.
Among them, 211 people (2.63%) have Death
Time on Tikosyn when people have Death :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Death | 35.29% | 35.29% | 11.76% | 0.00% | 17.65% | 0.00% | 0.00% |
On Jan, 10, 2017 8,033 people reported to have side effects when taking Tikosyn.
Among them, 8 people (0.1%) have Hallucination